glp-1 cardiovascular benefits glp 1 effect on heart receptor agonist-based therapies and risk: a review of mechanisms Frontiers Semaglutide Shows Secondary Cardiovascular Prevention

Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial

FOCUS, an ongoing, placebo-controlled, phase III study (ClinicalTrials.gov ID: is investigating the long-term effects of once-weekly subcutaneous semaglutide on the progression of diabetic retinopathy in individuals with T2DM

While there are no strictly forbidden foods on these medications, the way your body processes red meat changes significantly once you begin treatment

If you also take insulin or other glucose-lowering drugs, inform your doctor before adding moringa